| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 41 | 0 | 0 | 4 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | -41 | 0 | 0 | -4 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | -41 | 0 | 0 | -4 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Isomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 229 | 227 | 223 | 219 | 214 | 210 | 205 | 206 | 205 | 204 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Cash | 226 | 224 | 220 | 216 | 211 | 207 | 202 | 203 | 202 | 201 |
| Shareholders Funds | -7.361 | -7.286 | -7.162 | -7.031 | -6.936 | -6.804 | -6.654 | -6.678 | -6.658 | -6.621 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 7.590 | 7.513 | 7.386 | 7.250 | 7.150 | 7.014 | 6.859 | 6.884 | 6.863 | 6.825 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Isomedica Srl